These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 10591056)
1. MAO-A and -B gene knock-out mice exhibit distinctly different behavior. Shih JC; Chen K Neurobiology (Bp); 1999; 7(2):235-46. PubMed ID: 10591056 [TBL] [Abstract][Full Text] [Related]
2. Role of MAO A and B in neurotransmitter metabolism and behavior. Shih JC; Chen K; Ridd MJ Pol J Pharmacol; 1999; 51(1):25-9. PubMed ID: 10389141 [TBL] [Abstract][Full Text] [Related]
3. Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B. Shih JC Neurotoxicology; 2004 Jan; 25(1-2):21-30. PubMed ID: 14697877 [TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase: from genes to behavior. Shih JC; Chen K; Ridd MJ Annu Rev Neurosci; 1999; 22():197-217. PubMed ID: 10202537 [TBL] [Abstract][Full Text] [Related]
5. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion. Gal S; Zheng H; Fridkin M; Youdim MB J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414 [TBL] [Abstract][Full Text] [Related]
6. Progress in monoamine oxidase (MAO) research in relation to genetic engineering. Nagatsu T Neurotoxicology; 2004 Jan; 25(1-2):11-20. PubMed ID: 14697876 [TBL] [Abstract][Full Text] [Related]
7. Increased stress response and beta-phenylethylamine in MAOB-deficient mice. Grimsby J; Toth M; Chen K; Kumazawa T; Klaidman L; Adams JD; Karoum F; Gal J; Shih JC Nat Genet; 1997 Oct; 17(2):206-10. PubMed ID: 9326944 [TBL] [Abstract][Full Text] [Related]
8. Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl. Riederer P; Konradi C; Schay V; Kienzl E; Birkmayer G; Danielczyk W; Sofic E; Youdim MB Adv Neurol; 1987; 45():111-8. PubMed ID: 3030067 [TBL] [Abstract][Full Text] [Related]
9. Biochemical effects of the monoamine neurotoxins DSP-4 and MDMA in specific brain regions of MAO-B-deficient mice. Fornai F; Giorgi FS; Gesi M; Chen K; Alessrì MG; Shih JC Synapse; 2001 Mar; 39(3):213-21. PubMed ID: 11169770 [TBL] [Abstract][Full Text] [Related]
10. MAO-B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake. Lee M; Chen K; Shih JC; Hiroi N Genes Brain Behav; 2004 Aug; 3(4):216-27. PubMed ID: 15248867 [TBL] [Abstract][Full Text] [Related]
11. [Discovery of monoamine oxidase forms A and B]. Squires RF Vopr Med Khim; 1997; 43(6):433-9. PubMed ID: 9503561 [TBL] [Abstract][Full Text] [Related]
12. From genes to aggressive behavior: the role of serotonergic system. Popova NK Bioessays; 2006 May; 28(5):495-503. PubMed ID: 16615082 [TBL] [Abstract][Full Text] [Related]
13. Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice. Bortolato M; Godar SC; Tambaro S; Li FG; Devoto P; Coba MP; Chen K; Shih JC Neuropharmacology; 2013 Dec; 75():223-32. PubMed ID: 23871843 [TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effects of the extract of pilose antler on monoamine oxidase in aged mice]. Chen X; Jia Y; Wang B Zhongguo Zhong Yao Za Zhi; 1992 Feb; 17(2):107-10, 128. PubMed ID: 1418524 [TBL] [Abstract][Full Text] [Related]
15. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio). Anichtchik O; Sallinen V; Peitsaro N; Panula P J Comp Neurol; 2006 Oct; 498(5):593-610. PubMed ID: 16917825 [TBL] [Abstract][Full Text] [Related]
16. CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats. Aguiar LM; Macêdo DS; Vasconcelos SM; Oliveira AA; de Sousa FC; Viana GS Brain Res; 2008 Jan; 1191():192-9. PubMed ID: 18164694 [TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674 [TBL] [Abstract][Full Text] [Related]
19. Types A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats. Westwood NN; Bryan-Lluka LJ J Pharmacol Exp Ther; 1993 Nov; 267(2):815-21. PubMed ID: 8246156 [TBL] [Abstract][Full Text] [Related]
20. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors. Bainbridge JL; Page RL; Ruscin JM Neurol Clin; 2008 Aug; 26(3 Suppl):S85-96, vi. PubMed ID: 18774444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]